According to the latest data from the Hong Kong Stock Exchange, on May 15, Norges Bank purchased an additional 254,500 shares of Pharmaron (03759) at a price of HK$18.707 per share, with a total transaction value of approximately HK$4.7609 million. Following this acquisition, Norges Bank's total shareholding in the company has increased to about 24.9317 million shares, representing a 7.07% stake.